What Challenges Exist in the Development of Orphan Drugs?
Despite the incentives, the development of orphan drugs faces several challenges. Clinical trials for these drugs often have small sample sizes due to the rarity of the condition, making it difficult to demonstrate efficacy and safety conclusively. Additionally, the high cost of development and limited market potential can make it financially risky for pharmaceutical companies.
